跳至主要内容
临床试验/IRCT2016062518927N4
IRCT2016062518927N4已完成3 期

Effect of magnesium supplements as complementary treatment with methylphenidate in children with attention-deficit/hyperactivity disorder

Vice chancellor for research, Tabriz University of Medical Sciences.0 个研究点目标入组 40 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
7 years 至 12 years(—)
性别
All

入选标准

  • children between 7-12 aged; ADHD diagnosis by expert pediatric psychology physician using DSM diagnosis index; No prevention for Magnesium supplements; IQ index above 70; Without other psychology disorders; No intake of Magnesium supplements since 2 months ago; Intake of methylphenidate tablet with a dose of 0.5-1 mg/kg/day as a medical treatment. Exclusion criteria:Stop the treatment by the child or parents; incorrect intake of the drug by the child; change the treatment method; Stop the treatment due to the side effects of the drug; Acute physical disease.

排除标准

  • 未提供

研究者

发起方
Vice chancellor for research, Tabriz University of Medical Sciences.

相似试验